Cite
HARVARD Citation
Furukawa, S. et al. (2023). Decrease in in vivo coagulant potential of emicizumab in a patient with hemophilia A and inhibitor complicated with infectious mononucleosis. Blood coagulation and fibrinolysis. 34 (2), pp. 122-128. [Online].